17/11/2017 07:00:43

NeuroSearch upgrades its guidance for 2017

Related content
05 Dec - 
Update on NeuroSearch’s business status and future
31 Aug - 
NeuroSearch A/S – H1 report 2017
04 Jul - 
NeuroSearch and Saniona enter into agreement on transfe..
Related debate
19 Dec - 
Lige nu er muligheden i Neurosearch at købe bill..
14 Dec - 
http://www.bechbruun.com/-/media/Files/Videncenter/Arti..
14 Dec - 
Jeg opfatter nu ikke nohopes indlæg som specielt rettet..

Company announcement

17 November 2017

NeuroSearch upgrades its guidance for 2017 from an operating loss of DKK 2.3-3.3 million, to an operation loss of approximately DKK 1 million. The outlook does not include any income from the possible divestment of additional Company assets or potential income from the Company’s agreement with Teva.

Contact

Allan Andersen, CEO, mobile +45 4016 3864.

About NeuroSearch

NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.

 

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Alliance Trust PLC : Net Asset Value(s)

23/01/2018 13:47:03
ALLIANCE TRUST PLC                                    At the close of business on Monday 22 January 2018: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 814.7p -       including income, 818.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inco..

Investec Bank plc : Form 8.5 (EPT/RI) - Melrose Industries plc

23/01/2018 10:51:00
 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant ..

Man Group PLC : Form 8.3 - [UBM plc] - Amendment

22/01/2018 14:52:32
Amendment to cash-settled derivatives positions and transactions, sections 2(a) and 3(b). FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Post-stabilisation Pbb € 500mn senior 2022
2
Portola Pharmaceuticals Announces Acceptance of Late-Breaker Abstract Highlighting New Data for Andexanet Alfa at ACC.18
3
Southern Missouri Bancorp Reports Preliminary Results for Second Quarter of Fiscal 2018; Dividend of $0.11 Per Common Share Declared; Conference Call to Discuss Results Scheduled for Tuesday, January 23 at 3:30 P.m. Central Time
4
Simmons Reports Fourth Quarter 2017 Earnings
5
Microdrones and ASPRS to host Workshop Day, February 8th, in conjunction with the ILMF and ASPRS Conference in Denver, Colorado

Related stock quotes

NeuroSearch A/S 4.40 0.2% Stock price increasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 January 2018 15:32:56
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180122.2 - EUROWEB3 - 2018-01-23 16:32:56 - 2018-01-23 15:32:56 - 1000 - Website: OKAY